Topoisomerase II Inhibition Prevents Doxorubicin-Induced DNA Damage

被引：0
|
作者：
Roti, Elon C. Roti [1 ]
Salih, Sana M. [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
来源：
REPRODUCTIVE SCIENCES | 2011年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-117
引用
收藏
页码：279A / 279A
页数：1
相关论文
共 50 条
  • [41] Macrophages participate in doxorubicin-induced cardiac damage
    Cerasuolo, Federica Andrea
    Gambardella, Jessica
    Santulli, Gaetano
    Fiordelisi, Antonella
    Wang, Xujun
    Prevete, Nella
    Sommella, Edoardo
    Avvisato, Roberta
    Buonaiuto, Antonietta
    Altobelli, Giovanna Giuseppina
    Ciccarelli, Michele
    Morisco, Carmine
    Sadoshima, Junichi
    Iaccarino, Guido
    Sorriento, Daniela
    VASCULAR PHARMACOLOGY, 2024, 155 : 107309
  • [42] RELATIONSHIPS BETWEEN DNA-DAMAGE AND GROWTH-INHIBITION INDUCED BY TOPOISOMERASE II-INTERFERING DRUGS IN DOXORUBICIN-SENSITIVE AND DOXORUBICIN-RESISTANT RAT GLIOBLASTOMA CELLS
    DETINGUYMOREAUD, E
    POURQUIER, P
    MONTAUDON, D
    ROBERT, J
    ANTICANCER RESEARCH, 1994, 14 (1A) : 99 - 103
  • [43] Pretreatment of 3-MA prevents doxorubicin-induced cardiotoxicity through inhibition of autophagy initiation
    Sun, Xiaofan
    Meng, Heng
    Xiao, Jia
    Liu, Fangshu
    Du, Juan
    Zeng, Hui
    TOXICOLOGY, 2023, 490
  • [44] Inhibition of MMP prevents doxorubicin-induced cardiotoxicity by attenuating cardiac intracellular and extracellular matrix remodelling
    Rabinovich-Nikitin, Inna
    Love, Matthew
    Kirshenbaum, Lorrie A.
    CARDIOVASCULAR RESEARCH, 2021, 117 (01) : 11 - 12
  • [45] Inhibition of doxorubicin-induced mutagenicity by Baccharis dracunculifolia
    Resende, Flavia Aparecida
    Alves, Jacqueline Morais
    Munari, Carla Carolina
    Senedese, Juliana Marques
    Sousa, Joao Paulo B.
    Bastos, Jairo Kenupp
    Tavares, Denise Crispim
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2007, 634 (1-2) : 112 - 118
  • [46] Lovastatin protects cardiomyoblasts from doxorubicin-induced cytotoxicity by antagonizing topoisomerase II cleavable complex formation
    Huelsenbeck, S. C.
    Huelsenbeck, J.
    Fritz, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 49 - 49
  • [47] Evolution of Theories on Doxorubicin-Induced Late Cardiotoxicity-Role of Topoisomerase
    Szponar, Jaroslaw
    Ciechanski, Erwin
    Ciechanska, Magda
    Dudka, Jaroslaw
    Mandziuk, Slawomir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (24)
  • [48] Role of RHOA signaling in the doxorubicin-induced DNA damage response in mouse embryonic fibroblasts
    Franken, S.
    Fritz, G.
    Henninger, C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S60 - S60
  • [49] Cardioprotective Effects of Hesperetin against Doxorubicin-Induced Oxidative Stress and DNA Damage in Rat
    Trivedi, P. P.
    Kushwaha, S.
    Tripathi, D. N.
    Jena, G. B.
    CARDIOVASCULAR TOXICOLOGY, 2011, 11 (03) : 215 - 225
  • [50] Mercury(II) Impairs Processing of DNA damage Induced by Topoisomerase I
    Ursu, Giorgiana Madalina
    Zhitkovich, Anatoly
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2024, 65 : 87 - 88
12345